IP Library Granted Patent US 10,851,067
Granted Patent B2
US 10,851,067 · App. 16/358,642 · Granted Dec 1, 2020

Kv7 channel activators compositions and methods of use

Inventors: Michael E. Bozik (Wexford, PA); Scott S. Harried (Sun Prairie, WI); Lynn Resnick (Pittsburgh, PA); George T. Topalov (Pittsburgh, PA); Justin K. Belardi (Pittsburgh, PA); Charles A. Flentge (Mars, PA); David A. Mareska (McMurray, PA); James S. Hale (Pittsburgh, PA)
Assignee: Knopp Biosciences LLC
C07D235/30C07D405/04C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,851,067
App. No.
16/358,642
Granted
Dec 1, 2020
Kind
B2
Abstract

Provided herein are optionally substituted benzoimidazol-1,2-yl amides, pharmaceutical compositions comprising a therapeutically effective amount of such compounds and a pharmaceutically acceptable excipient, and methods of treating Kv7 associated diseases, such as, epilepsy, amyotrophic lateral sclerosis, various types of pain, hyperexcitability, a dyskinesia, dystonia, mania and tinnitus with such compounds and pharmaceutical compositions.

Claims (43)

1. A compound selected from the group consisting of:

or a

pharmaceutically acceptable salt thereof.

2. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

3. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

4. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

5. A pharmaceutical composition comprising a compound of claim 1 .

6. A pharmaceutical composition comprising a compound of claim 2 .

7. A pharmaceutical composition comprising a compound of claim 3 .

8. A pharmaceutical composition comprising a compound of claim 4 .

9. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

10. A pharmaceutical composition comprising a compound of claim 9 .

11. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

12. A pharmaceutical composition comprising a compound of claim 11 .

13. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

14. A pharmaceutical composition comprising a compound of claim 13 .

15. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

16. A pharmaceutical composition comprising a compound of claim 15 .

17. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

18. A pharmaceutical composition comprising a compound of claim 17 .

19. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

20. A pharmaceutical composition comprising a compound of claim 19 .

21. The compound of claim 2 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

22. A pharmaceutical composition comprising a compound of claim 21 .

23. The compound of claim 2 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

24. A pharmaceutical composition comprising a compound of claim 23 .

25. The compound of claim 2 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

26. A pharmaceutical composition comprising a compound of claim 25 .

27. The compound of claim 3 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

28. A pharmaceutical composition comprising a compound of claim 27 .

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2022
From: AMERICAN MONEY MANAGEMENT CORPORATION
To: KNOPP BIOSCIENCES LLC
Reel/Frame 059572/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2022
From: CHANNEL BIOSCIENCES, LLC
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 059598/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2022
From: KNOPP BIOSCIENCES LLC
To: CHANNEL BIOSCIENCES, LLC
Reel/Frame 059681/0638 →
SECURITY INTEREST Recorded Apr 12, 2021
From: KNOPP BIOSCIENCES LLC
To: AMERICAN MONEY MANAGEMENT CORPORATION
Reel/Frame 055889/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2019
From: BELARDI, JUSTIN K.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050316/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: MARESKA, DAVID A.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: TOPALOV, GEORGE T.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: HARRIED, SCOTT S.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: RESNICK, LYNN
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: BOZIK, MICHAEL E.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: FLENTGE, CHARLES A.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2019
From: HALE, JAMES S.
To: KNOPP BIOSCIENCES LLC
Reel/Frame 050228/0519 →
Continuity (5)
Provisional Application 62697198 · Jul 12, 2018
Provisional Application 62663438 · Apr 27, 2018
Provisional Application 62644902 · Mar 19, 2018
Provisional Application 62644932 · Mar 19, 2018
Related Publication 20190284142A1 · Sep 19, 2019
Cited By (2)
US 12,286,408 US 12,351,559